Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP351637.RAewh-rSKY2JUSQCpYTB_ZCJjmn0F0sDgYiILzFChOX3w130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP351637.RAewh-rSKY2JUSQCpYTB_ZCJjmn0F0sDgYiILzFChOX3w130_provenance.
• NP454098.RAr1JB5VNFaDFUnQMJ8DSg3lAb8J1rKuVQ5bJX3XIDWnc130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454098.RAr1JB5VNFaDFUnQMJ8DSg3lAb8J1rKuVQ5bJX3XIDWnc130_provenance.
• NP196621.RA0pEb6GegHRJWrvcnw3IZiw92SPVmHmou6oJ4ZWJ16Ds130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP196621.RA0pEb6GegHRJWrvcnw3IZiw92SPVmHmou6oJ4ZWJ16Ds130_provenance.
• NP375381.RAKOANW8Fq_jo5Qziwf7pwG0STfpOoCnWiC-XmKMgwE8o130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375381.RAKOANW8Fq_jo5Qziwf7pwG0STfpOoCnWiC-XmKMgwE8o130_provenance.
• NP570965.RAX4s01a7Uo0r1c9BUwr85L5dTsFFgZ6lF06oYnsYlQso130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570965.RAX4s01a7Uo0r1c9BUwr85L5dTsFFgZ6lF06oYnsYlQso130_provenance.
• NP571290.RAag1KUEDZ3XPXljTg72e3VHv3Adu2Es9nL1JLIptHs0o130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571290.RAag1KUEDZ3XPXljTg72e3VHv3Adu2Es9nL1JLIptHs0o130_provenance.
• NP570881.RAem-ttDeKqdnTfbAVEA__0siZHkT38fRB5vjqI8SGegQ130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570881.RAem-ttDeKqdnTfbAVEA__0siZHkT38fRB5vjqI8SGegQ130_provenance.
• assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP738272.RAiw3tTJSl37nQluAdnOEnJI7eZXviivG9kARH51u1msA130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738272.RAiw3tTJSl37nQluAdnOEnJI7eZXviivG9kARH51u1msA130_provenance.
• NP427281.RAQI7DnQCdxgv0Hv68BTVNBiIbxLp8wfBz63QPOXhIllM130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427281.RAQI7DnQCdxgv0Hv68BTVNBiIbxLp8wfBz63QPOXhIllM130_provenance.
• NP427283.RAbLCPF-2gBDRM2ocOJGMgXQVi1RcV5IjR54laTwBYRIk130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427283.RAbLCPF-2gBDRM2ocOJGMgXQVi1RcV5IjR54laTwBYRIk130_provenance.
• NP571311.RApKFvIqcK9S6hnO0Aq07dEixmaAVOsLXh0zWwLaHp4JI130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571311.RApKFvIqcK9S6hnO0Aq07dEixmaAVOsLXh0zWwLaHp4JI130_provenance.
• NP571426.RAqUKiaTklL1KLrt4xLc8VmPdtvuYL2jzW9r7MxbTDQDk130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571426.RAqUKiaTklL1KLrt4xLc8VmPdtvuYL2jzW9r7MxbTDQDk130_provenance.
• NP959725.RAooHef5z78YpqK_OdeRwPiPBvD1Mzs8_ds1CPCShepZI130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP959725.RAooHef5z78YpqK_OdeRwPiPBvD1Mzs8_ds1CPCShepZI130_provenance.
• NP954424.RAgwxoCXu7gqPbel5le5pqLyLSILYyazmwUa8-XmX0B8Y130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954424.RAgwxoCXu7gqPbel5le5pqLyLSILYyazmwUa8-XmX0B8Y130_provenance.
• NP427279.RAv3TvYa2mwToapWj5-29TnQ9CV2qzuaU18rzJlgQIj3M130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427279.RAv3TvYa2mwToapWj5-29TnQ9CV2qzuaU18rzJlgQIj3M130_provenance.
• NP427282.RAjNLYsUp3t4gXIh52WcgwhQ-clDHWVdGtcDWTRKgLfhs130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427282.RAjNLYsUp3t4gXIh52WcgwhQ-clDHWVdGtcDWTRKgLfhs130_provenance.
• NP427285.RAqzkQge08Vze9hW9RS7jSc2IpzZf1-0ZWkz6c5QAs0tQ130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427285.RAqzkQge08Vze9hW9RS7jSc2IpzZf1-0ZWkz6c5QAs0tQ130_provenance.
• NP570890.RAPAExDHyHtBOqjhFIaTLU1rJPLzQmqns9NjVvYLJkOlk130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570890.RAPAExDHyHtBOqjhFIaTLU1rJPLzQmqns9NjVvYLJkOlk130_provenance.
• NP954364.RAGp9lFPDdpD_SazIoUW06ZO6LvjidL0UMev59c-Mh5LQ130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954364.RAGp9lFPDdpD_SazIoUW06ZO6LvjidL0UMev59c-Mh5LQ130_provenance.
• NP427288.RAF_ZhYoeXvYMu4WyyLuLBdZZJDTrBaSJnpk-zA3V_c8Q130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427288.RAF_ZhYoeXvYMu4WyyLuLBdZZJDTrBaSJnpk-zA3V_c8Q130_provenance.
• NP427280.RA-FyB2IJE4uhCyiGUo9Y6dHMmM3_witoJW1ExNrweDGc130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427280.RA-FyB2IJE4uhCyiGUo9Y6dHMmM3_witoJW1ExNrweDGc130_provenance.
• NP427287.RA7lGLoP5zVg8SccnY78WpO9pN2C66nY_fWZolvVprtNo130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427287.RA7lGLoP5zVg8SccnY78WpO9pN2C66nY_fWZolvVprtNo130_provenance.
• NP954357.RA7BVR3057GpU8XzXQIaUh7D6-TgH6l17bPJR2O9M7AyI130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954357.RA7BVR3057GpU8XzXQIaUh7D6-TgH6l17bPJR2O9M7AyI130_provenance.
• NP959733.RA0TutVkYPu7IzI4ZEFZLXf-Qul8dqGr5nxjDd9X7VKiU130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP959733.RA0TutVkYPu7IzI4ZEFZLXf-Qul8dqGr5nxjDd9X7VKiU130_provenance.
• NP959802.RAy-4TDYd6sYvRgdk_dSHmx6ESD0YEei7CEW6qWSKxbjg130_assertion description "[Bisulfite-modified DNA sequencing and MSP assay showed aberrant methylation of TIMP-2 5'-CpG island in 17 of 36 (47%) invasive cervical carcinomas and in 2 of 3 cervical cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP959802.RAy-4TDYd6sYvRgdk_dSHmx6ESD0YEei7CEW6qWSKxbjg130_provenance.